Yichun Ning

1.2k total citations · 1 hit paper
28 papers, 871 citations indexed

About

Yichun Ning is a scholar working on Molecular Biology, Nephrology and Pathology and Forensic Medicine. According to data from OpenAlex, Yichun Ning has authored 28 papers receiving a total of 871 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Nephrology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Yichun Ning's work include Acute Kidney Injury Research (6 papers), Chemotherapy-induced organ toxicity mitigation (5 papers) and Chronic Kidney Disease and Diabetes (4 papers). Yichun Ning is often cited by papers focused on Acute Kidney Injury Research (6 papers), Chemotherapy-induced organ toxicity mitigation (5 papers) and Chronic Kidney Disease and Diabetes (4 papers). Yichun Ning collaborates with scholars based in China and United States. Yichun Ning's co-authors include Nana Song, Yiqin Shi, Yi Fang, Guangyan Cai, Xiangmei Chen, Xuefeng Sun, Yang Li, Xiaoqiang Ding, Shaoyuan Cui and Dan Dong and has published in prestigious journals such as Scientific Reports, Kidney International and Biochemical Pharmacology.

In The Last Decade

Yichun Ning

27 papers receiving 866 citations

Hit Papers

Temporal trends in prevalence and mortality for chronic k... 2022 2026 2023 2024 2022 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yichun Ning China 17 375 188 163 113 109 28 871
Elettra Mancuso Italy 11 213 0.6× 122 0.6× 154 0.9× 120 1.1× 35 0.3× 25 678
Xiaojuan Bai China 14 131 0.3× 66 0.4× 151 0.9× 68 0.6× 28 0.3× 48 529
Yi Guan China 11 200 0.5× 134 0.7× 91 0.6× 111 1.0× 33 0.3× 20 622
Yodo Tamaki Japan 17 402 1.1× 29 0.2× 243 1.5× 185 1.6× 89 0.8× 56 1.1k
S. Jeson Sangaralingham United States 25 290 0.8× 118 0.6× 95 0.6× 51 0.5× 33 0.3× 66 1.5k
Nobuyuki Shirai Japan 13 129 0.3× 101 0.5× 298 1.8× 24 0.2× 24 0.2× 33 679
Michael D. Brown United States 17 328 0.9× 35 0.2× 265 1.6× 98 0.9× 125 1.1× 37 1.1k
Mojca Jensterle Slovenia 30 390 1.0× 218 1.2× 238 1.5× 168 1.5× 50 0.5× 110 2.4k
Andrea Baessler Germany 20 330 0.9× 66 0.4× 219 1.3× 230 2.0× 46 0.4× 53 1.1k
Tomoko Ichiki United States 22 261 0.7× 56 0.3× 96 0.6× 54 0.5× 64 0.6× 69 1.2k

Countries citing papers authored by Yichun Ning

Since Specialization
Citations

This map shows the geographic impact of Yichun Ning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yichun Ning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yichun Ning more than expected).

Fields of papers citing papers by Yichun Ning

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yichun Ning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yichun Ning. The network helps show where Yichun Ning may publish in the future.

Co-authorship network of co-authors of Yichun Ning

This figure shows the co-authorship network connecting the top 25 collaborators of Yichun Ning. A scholar is included among the top collaborators of Yichun Ning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yichun Ning. Yichun Ning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ning, Yichun, Ji Ji, Min Lu, et al.. (2025). Both carvedilol and cimetidine alleviate cisplatin-induced nephrotoxicity via downregulating OCT2. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1871(5). 167754–167754.
2.
Hong, Fu‐Yuan, Hong Liu, Yi Fang, et al.. (2025). FTO aggravates podocyte injury and diabetic nephropathy progression via m6A-dependent stabilization of ACC1 mRNA and promoting fatty acid metabolism. Biochemical Pharmacology. 235. 116819–116819. 3 indexed citations
3.
Yang, Qiang, Yichun Ning, Shuan Zhao, et al.. (2023). A NOVEL RAT MODEL OF CONTRAST-INDUCED ACUTE KIDNEY INJURY BASED ON RENAL CONGESTION AND THE RENO-PROTECTION OF MITOCHONDRIAL FISSION INHIBITION. Shock. 59(6). 930–940. 3 indexed citations
4.
Lu, Yufei, Yichun Ning, Yang Li, et al.. (2023). Risk factor mining and prediction of urine protein progression in chronic kidney disease: a machine learning- based study. BMC Medical Informatics and Decision Making. 23(1). 173–173. 4 indexed citations
6.
Lu, Zhihui, Hong Liu, Nana Song, et al.. (2021). METTL14 aggravates podocyte injury and glomerulopathy progression through N6-methyladenosine-dependent downregulating of Sirt1. Cell Death and Disease. 12(10). 881–881. 90 indexed citations
9.
Ning, Yichun, Jing Chen, Yiqin Shi, et al.. (2020). Genistein Ameliorates Renal Fibrosis Through Regulation Snail via m6A RNA Demethylase ALKBH5. Frontiers in Pharmacology. 11. 579265–579265. 59 indexed citations
10.
Cai, Guangyan, Yichun Ning, Jingchao Wang, et al.. (2020). Caloric restriction alleviates aging-related fibrosis of kidney through downregulation of miR-21 in extracellular vesicles. Aging. 12(18). 18052–18072. 30 indexed citations
11.
Chen, Jing, Yulu Gu, Han Zhang, et al.. (2019). Amelioration of Uremic Toxin Indoxyl Sulfate-Induced Osteoblastic Calcification by SET Domain Containing Lysine Methyltransferase 7/9 Protein. ˜The œNephron journals/Nephron journals. 141(4). 287–294. 16 indexed citations
12.
Cai, Jieru, Xiaoyan Jiao, Shuan Zhao, et al.. (2019). Transforming growth factor-β1-overexpressing mesenchymal stromal cells induced local tolerance in rat renal ischemia/reperfusion injury. Cytotherapy. 21(5). 535–545. 13 indexed citations
13.
Chen, Jing, Yichun Ning, Han Zhang, et al.. (2019). METTL14-dependent m6A regulates vascular calcification induced by indoxyl sulfate. Life Sciences. 239. 117034–117034. 57 indexed citations
14.
Ning, Yichun, Yiqin Shi, Jing Chen, et al.. (2018). Necrostatin-1 Attenuates Cisplatin-Induced Nephrotoxicity Through Suppression of Apoptosis and Oxidative Stress and Retains Klotho Expression. Frontiers in Pharmacology. 9. 384–384. 43 indexed citations
15.
Liu, Dong, Yichun Ning, Ying Zhang, et al.. (2018). Youthful systemic milieu alleviates renal ischemia-reperfusion injury in elderly mice. Kidney International. 94(2). 268–279. 32 indexed citations
16.
Lu, Zhihui, Nana Song, Bo Shen, et al.. (2018). Syndecan-1 Shedding Inhibition to Protect Against Ischemic Acute Kidney Injury Through HGF Target Signaling Pathway. Transplantation. 102(7). e331–e344. 25 indexed citations
17.
Wang, Wenjuan, Guangyan Cai, Yichun Ning, et al.. (2016). Hydrogen sulfide mediates the protection of dietary restriction against renal senescence in aged F344 rats. Scientific Reports. 6(1). 30292–30292. 30 indexed citations
18.
Ning, Yichun, Guangyan Cai, Li Zhuo, et al.. (2014). Beneficial Effects of Short-Term Calorie Restriction against Cisplatin-Induced Acute Renal Injury in Aged Rats. Nephron Experimental Nephrology. 124(3-4). 19–27. 42 indexed citations
19.
Ning, Yichun, Guangyan Cai, Jianjun Gao, et al.. (2013). Short-term calorie restriction protects against renal senescence of aged rats by increasing autophagic activity and reducing oxidative damage. Mechanisms of Ageing and Development. 134(11-12). 570–579. 72 indexed citations
20.
Gao, Jianjun, Guangyan Cai, Yichun Ning, et al.. (2012). DAP5 Ameliorates Cisplatin-Induced Apoptosis of Renal Tubular Cells. American Journal of Nephrology. 35(5). 456–465. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026